Hennion & Walsh Asset Management, Inc.

Position in QURE — uniQure N.V.

CIK 1861642 Parsippany, NJ

Position in QURE

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$6,545,724

+$5,424,981 QoQ

Shares Held

142,113

+107.3% QoQ

Ownership

0.225%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

of 7 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

Hennion & Walsh Asset Management, Inc. holds $200,308,891 across 60 Biotechnology names. QURE ranks #6 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	48,019	$11,571,138
2	CELC	Celcuity Inc.	100,368	$10,500,500
3	URGN	UroGen Pharma Ltd.	276,696	$10,182,412
4	TVTX	Travere Therapeutics, Inc.	171,470	$9,741,210
5	SNDX	Syndax Pharmaceuticals Inc	342,883	$7,495,422
6	QURE	uniQure N.V. This page	142,113	$6,545,724
7	KURA	Kura Oncology, Inc.	568,845	$6,240,229
8	ARDX	Ardelyx, Inc.	1,211,690	$6,179,619

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,545,724	142,113	+107.3%	Shares	Sole	2026-07-08
2026-03-31	$1,120,743	68,547	+1.2%	Shares	Sole	2026-05-13
2025-12-31	$1,620,994	67,739	+31.2%	Shares	Sole	2026-01-14
2025-09-30	$3,012,650	51,613	+70.0%	Shares	Sole	2025-10-22
2025-06-30	$423,343	30,369	-47.3%	Shares	Sole	2025-08-07
2022-09-30	$1,080,350	57,588	-5.3%	Shares	Sole	2022-11-14
2022-06-30	$1,134,113	60,843	-4.4%	Shares	Sole	2022-07-19
2022-03-31	$1,150,516	63,670	-3.5%	Shares	Sole	2022-04-26
2021-12-31	$1,368,031	65,961	-28.4%	Shares	Sole	2022-02-14
2021-09-30	$2,950,201	92,165	-2.6%	Shares	Sole	2021-11-12
2021-06-30	$2,914,388	94,623	-3.5%	Shares	Sole	2021-08-13
2021-03-31	$3,304,854	98,096	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.